Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Nutrigenomics involves the determination of genetic sequence to help design a diet according to the assumed reaction by the genetic build-up. It investigates the relationship between nutrition & genome and helps understand the reaction of body to specific foods, supplements & beverages and thus provides ultimate consequence to a solid basis for nutritional advice. However, diet is an important modifiable determinant of disease and it is becoming clear that diet and genetic risk factors are interactive in defining risk for diseases such as cardiovascular disease, diabetes and cancers. The increased need for the use of personalised nutrition in patients is increasing and research is being made on its possible effects. Furthermore, advances in technology have improved understanding of gene-nutrient interactions and lead to the development of nutrigenomics. Moreover, nutrigenomics also has the potential to influence the distinct parts of a food chain such as genetic alteration of crops and animal feed.
The nutrigenomics market is remarkably driven by the increasing advancement in the field of metabolomics, computational biology, proteomics, genomics and bioinformatics. Furthermore, rising diabetic & obese population, increasing demand for the advanced diagnostic methods and high applications demand in dermatology has fuelled the market growth. Moreover, government support for research & development and increasing healthcare expenditure are further contributing for the growth of this market. However, requirement of skilled physicians and high cost of treatment is hindering the market growth.
The nutrigenomics market is segmented by product, test sample, application, age group and geography.
Based on product, the global market is segmented into reagents & kits and services. The reagents & kits segment accounted for the largest market share in 2018, due to development of new nutrigenomic testing kits with accurate and fast results.
On the basis of test sample, the nutrigenomics market is segmented into saliva, buccal swab, blood. Among these, the saliva segment dominated the market in 2018, owing to surging use of saliva samples for DNA testing worldwide. The saliva samples are used by several healthcare professionals to analyse DNA for genetic variants that affect response to foods and beverages.
By application, the nutrigenomics market regulates and controls various diseases/conditions such as obesity, diabetes, anti-aging and chronic diseases. Owing to the presence of huge population suffering from overweightness, the obesity segment dominated the nutrigenomics market in 2018. Moreover, the diabetes segment is anticipated to grow at a fastest CAGR during the forecast period 2020 to 2025.
By age group, the nutrigenomics market is segmented into 0-18 age group, 19-34 age group, 35-54 age group and 55 + age group. Among various age groups, the 19-34 age group dominated the global nutrigenomics market in 2018. The growth of 19-34 age group segment is driven by increasing number of adult populations opting for nutrigenomic testing services in developed countries.
By geography, the nutrigenomics market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, and Rest of the world. North America comprises U.S., Canada and Mexico, whereas Europe would primarily cover Germany, the U.K., France, Italy and Rest of Europe. The key countries included under Asia Pacific are China, Japan, India, and Rest of Asia Pacific. Rest of the world include Latin America and Middle East and Africa (MEA). North America dominated the global nutrigenomics market in 2018, owing to the presence of huge population suffering from diabetes and obesity. Moreover, the Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increase in scientific development and advancement in health care services during the forecast period 2020 to 2025.
Some of the major players operating in the nutrigenomics market are WellGen Inc., DNAlife, Metagenics, Inc, Genomix Nutrition, Inc., Nutrigenomix, NutraGene and Cura Integrative Medicine. Market players are involved in new product launches and mergers & acquisitions to exploit maximum revenue potential in global market. For instance, in January 2017, Genomix Nutrition, Inc. launched a 55 Gene Nutrigenomic Testing Platform, allowing patients more insight into their individual DNA and giving healthcare providers the opportunity to support their patient’s nutrition based on their individual DNA.
The nutrigenomics market is segmented by product, techniques, application, age group and geography. Based on product, the global market is segmented into reagents & kits and services. The reagents & kits segment accounted for the largest market share in 2018, due to development of new nutrigenomic testing kits with accurate and fast results. On the basis of test sample, the nutrigenomics market is segmented into saliva, buccal swab, blood. Among these, the saliva segment dominated the market in 2018, owing to surging use of saliva samples for DNA testing worldwide. The saliva samples are used by several healthcare professionals to analyse DNA for genetic variants that affect response to foods and beverages. By application, the nutrigenomics market regulates and controls various diseases/conditions such as obesity, diabetes, anti-aging and chronic diseases. Owing to the presence of huge population suffering from overweightness, the obesity segment dominated the nutrigenomics market in 2018. By age group, the nutrigenomics market is segmented into 0-18 age group, 19-34 age group, 35-54 age group and 55 + age group. Among various age groups, the 19-34 age group dominated the global nutrigenomics market in 2018. The growth of 19-34 age group segment is driven by increasing number of adult populations opting for nutrigenomic testing services in developed countries. By geography, North America dominated the global nutrigenomics market in 2018, owing to the presence of huge population suffering from diabetes and obesity. Moreover, the Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increase in scientific development and advancement in health care services during the forecast period 2020 to 2025.
Why to buy this report:
